Su Zhen has filed 6 insider transactions across 2 companies since August 2023.
Most recent transaction: a grant/award of 38000 shares of CytomX Therapeutics, Inc. ($CTMX) on June 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2025 | CytomX Therapeutics, Inc. | $CTMX | Su Zhen | Not found | A | Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 80,099,889 | 9999.99% | 0.05% |
| May 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Su Zhen | Not found | A | Nonstatutory Stock Option (right to buy) | 4600 | $0.00 | 4,600.0000 | 126,240,054 | 9999.99% | 0.00% |
| May 29, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Su Zhen | Not found | A | Nonstatutory Stock Option (right to buy) | 50587 | $0.00 | 50,587.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | CytomX Therapeutics, Inc. | $CTMX | Su Zhen | Not found | A | Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2024 | CytomX Therapeutics, Inc. | $CTMX | Su Zhen | Not found | A | Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 31, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Su Zhen | Director | A | Nonstatutory Stock Option (right to buy) | 68000 | $0.00 | 68,000.0000 | 0 | 9999.99% | 0.00% |